#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Ocular myasthenia Alpha-1 antitrypsin deficiency Dilated cardiomyopathy Familial amyotrophic lateral sclerosis Myasthenia gravis Squamous cell carcinoma of the vulva Pleural mesothelioma malignant Skin angiosarcoma KBG syndrome ABO haemolytic disease of newborn Oesophageal adenocarcinoma stage III HER2 mutant non-small cell lung cancer Enteritis Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Trials in Disease Hepatoblastoma – Life with Disease Niemann-Pick disease – Trials in Disease Mucopolysaccharidosis I – Life with Disease Krabbe’s disease – Trials in Disease Epidermolysis bullosa – Basic Information Waldenstrom’s macroglobulinaemia refractory – Diagnostics Hereditary angioedema – Life with Disease Loeys-Dietz syndrome – Life with Disease Mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vigabatrin Quercetin Pseudoephedrine Hydrochloride Elraglusib AMMONIUM (15N) CHLORIDE Tofogliflozin Batoclimab Xxb750 Alx148 RIKKUNSHITO Etidronate Disodium Ammonium Chloride Cefuroxime Misoprostol Acemetacin Sodium Valproate IHMA-2121908-1 Bi 685509 Atorvastatin Sodium Glycerophosphate More therapies…

    Learn about Your Condition

    Diarrhoea Anal incontinence Chondrosarcoma Adrenocortical carcinoma Exudative retinopathy Endolymphatic hydrops Bone metabolism disorder Pre-eclampsia Deafness traumatic Lysosomal storage disorder Aortic disorder Interstitial lung disease Non-small cell lung cancer Chorioretinitis Brain stem glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study on Exercise, Mediterranean Diet, and Aspirin for Women with Infertility Undergoing In Vitro Fertilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain

  • Study on Prednisolone for Women with Unexplained Recurrent Miscarriages

    Recruiting

    3 1 1
    Investigated Diseases:
    • Habitual abortion
    Investigated Drugs:
    • Prednisolone
    The Netherlands

  • Study on Pregnancy Rates in Women with Polycystic Ovary Syndrome Using Letrozole and Gonadotropins

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Follitropin Beta
    Spain

  • Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Misoprostol
    Sweden

  • Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Bupivacaine Hydrochloride, Anhydrous
    • Extract Of Fresh Opium Poppy (1:2.2-2.7), Extraction Solvent: Ethanol 31.2 % (M/M)
    Sweden

  • Study on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)

    Recruiting

    4 1 1
    Investigated Drugs:
    • Sibeprenlimab
    Belgium Croatia Czechia France Germany Greece +6
Previous Page
1 … 12 13 14 15 16 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!